|
CPSF6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.241640E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.635300E-03 |
| Normal-vs-Stage2 |
2.138000E-03 |
| Normal-vs-Stage3 |
5.54779999999422E-05 |
| Normal-vs-Stage4 |
1.583320E-04 |
| Stage1-vs-Stage2 |
3.114000E-01 |
| Stage1-vs-Stage3 |
5.334000E-02 |
| Stage1-vs-Stage4 |
1.303980E-01 |
| Stage2-vs-Stage3 |
7.021600E-01 |
| Stage2-vs-Stage4 |
6.990000E-01 |
| Stage3-vs-Stage4 |
9.595000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.999300E-04 |
| Normal-vs-AfricanAmerican |
6.471500E-02 |
| Normal-vs-Asian |
5.111900E-02 |
| Caucasian-vs-AfricanAmerican |
6.926600E-01 |
| Caucasian-vs-Asian |
3.892600E-01 |
| AfricanAmerican-vs-Asian |
8.186400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.104630E-03 |
| Normal-vs-Female |
2.227500E-04 |
| Male-vs-Female |
7.638000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.999600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.991600E-04 |
| Normal-vs-Age(61-80Yrs) |
3.92460000000483E-05 |
| Normal-vs-Age(81-100Yrs) |
2.904200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.184000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.117800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.800400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.199800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.016800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.349600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.997600E-02 |
| Classical-VS-Follicular |
9.358800E-03 |
| Classical-VS-Other |
5.653600E-01 |
| Classical-VS-Normal |
1.305760E-02 |
| Tall-VS-Follicular |
9.741000E-01 |
| Tall-VS-Other |
7.283400E-01 |
| Tall-VS-Normal |
2.241800E-04 |
| Follicular-VS-Other |
7.074800E-01 |
| Follicular-VS-Normal |
8.34240000000541E-05 |
| Other-VS-Normal |
1.363180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.43230000000528E-05 |
| Normal-vs-N1 |
5.544800E-03 |
| N0-vs-N1 |
8.470400E-01 |
|
|
